Halozyme partners with Oruka for psoriasis drug development deal
Go back to Halozyme partners with Oruka for psoriasis drug development deal| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 106.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.12 | 52 Week High | $18.39 | |||
| Open | $106.12 | 52 Week Low | $6.96 | |||
| Day High | $106.12 | P/E | N/A | |||
| Day Low | $106.12 | EPS | $-0.58 | |||
| Volume | 241 | |||||
| (NASDAQ: ORKA) | Delayed: 104.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.86 | 52 Week High | $ | |||
| Open | $104.86 | 52 Week Low | $ | |||
| Day High | $104.86 | P/E | N/A | |||
| Day Low | $104.86 | EPS | $ | |||
| Volume | 3,731 | |||||
